GSS genetic signatures limited

Ann: Quarterly update and Appendix 4C, page-8

  1. 69 Posts.
    lightbulb Created with Sketch. 5
    It's hard not to lose patience, when the company couldn't even complete the FDA submission after many assurances. Not sure what the latest snag might be. It is perhaps not so simple and it shows that the company lacks FDA expertise. Meanwhile, the cash position of the company has turned from solid to being shaky and slowly turning towards critical. A sense of urgency is needed, but unfortunately not observed so far.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
36.5¢
Change
-0.010(2.67%)
Mkt cap ! $82.90M
Open High Low Value Volume
36.5¢ 36.5¢ 36.5¢ $160 438

Buyers (Bids)

No. Vol. Price($)
3 19601 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 32411 1
View Market Depth
Last trade - 13.38pm 04/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.